Nasal tumors in dogs.

What it is

Canine nasal tumors arise from the cells lining the nasal cavity or its surrounding bone and cartilage. The most common types are adenocarcinoma (most common overall), chondrosarcoma, squamous cell carcinoma, and undifferentiated carcinoma. All are locally aggressive — they invade the nasal cavity, cribriform plate, and sometimes the brain or surrounding facial structures.

Long-nosed (dolichocephalic) breeds — Collies, German Shepherds — have higher reported incidence than short-nosed breeds, possibly because their larger nasal turbinate surface area provides more cells at risk. Living in urban environments and exposure to certain combustion products have been weakly associated in some studies.

Signs to watch for

• Chronic nasal discharge — often starting unilateral (one nostril) and becoming bilateral as the tumor advances. May be clear, mucopurulent, or blood-tinged.
• Frequent sneezing or reverse sneezing.
• Facial deformity or asymmetry as the tumor expands into surrounding bone.
• Loss of nasal airflow on one side (you can sometimes test by holding a tuft of fur near each nostril).
• Neurologic signs (seizures, behavior change) if the tumor invades through the cribriform plate into the brain.

How veterinarians diagnose it

Skull and dental radiographs can suggest a nasal mass but rarely give a definitive answer — bony changes appear late.

CT (or MRI) of the head is the imaging standard. CT visualizes the tumor, defines its extent, and provides the planning information needed for radiation therapy.

Definitive diagnosis requires biopsy — done via rhinoscopy or blind nasal flush at most clinics, or as a CT-guided procedure at referral. Histopathology identifies the specific tumor type, which affects treatment recommendations only modestly.

Staging — chest radiographs (lung metastasis is relatively uncommon at diagnosis but can develop later) and regional lymph node aspiration.

What treatment usually looks like

• Radiation therapy is the treatment of choice for most canine nasal tumors. Stereotactic radiation (SRS/SRT) at referral centers delivers high-dose treatment in a small number of sessions; conventional fractionated radiation is delivered over weeks at facilities without SRS capacity. Local control and quality-of-life improvement are typically substantial.
• Surgery alone is rarely curative because complete margins are essentially impossible to achieve in the nasal cavity. Cytoreductive surgery before radiation is occasionally used.
• Chemotherapy (carboplatin, doxorubicin, or others) has modest activity and is sometimes used adjunctively or for late-stage disease — benefit is variable.
• Palliative options — intranasal stenting, NSAIDs, and pain control — when definitive radiation isn't pursued.

Prognosis

Without treatment, median survival is short — typically a few months from diagnosis as the tumor progresses locally.

With definitive radiation therapy, published median survival is in the range of about 12–18 months for many cases, with substantial individual variation. Stereotactic radiation has shown encouraging results in dedicated case series. Tumor stage and the presence of cribriform plate or brain involvement are the strongest negative prognostic factors.

Questions to ask your vet

• What did the CT and biopsy show — type and extent?
• Has the cribriform plate been breached?
• Is stereotactic or conventional radiation available within reach?
• What's the realistic survival range for our specific stage?
• What does pain management and palliative care look like if we don't pursue radiation?

Where to learn more

Veterinary teaching hospitals at most accredited US vet schools maintain owner-facing fact sheets on common cancers. Peer-reviewed journals — JAVMA, Veterinary and Comparative Oncology, Frontiers in Veterinary Science — are accessible through PubMed. The American College of Veterinary Internal Medicine (ACVIM) and the Veterinary Cancer Society publish consensus statements you can ask your vet to walk you through.

For clinical trials enrolling dogs with this diagnosis, see the SciRouter Vet trial finder — we index AVMA, NCI COTC, and twelve university registries.